duolin
rex medical ltd - ipratropium bromide monohydrate 525ug equivalent to 500 µg ipratropium bromide anhy./dose; salbutamol sulfate 3mg equivalent to 2.5 mg salbutamol/dose - solution for inhalation - 500µg/2.5mg per dose - active: ipratropium bromide monohydrate 525ug equivalent to 500 µg ipratropium bromide anhy./dose salbutamol sulfate 3mg equivalent to 2.5 mg salbutamol/dose excipient: purified water sodium chloride sulfuric acid - duolin is indicated for the treatment of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.
duolin respules
cipla-medpro (pty) ltd - ipratropium bromide, salbutamol sulphate - solution - each 2,5 ml solution contains ipratropium bromide 0,5 mg, salbutamol sulphate equiv. to salbutamol 2,5 mg
sultolin solution 2.5mg/2.5ml
square pharmaceuticals limited, bangladesh - salbutamol - solution - 2.5mg/2.5ml
duolin respules solution
cipla medpro (pty) ltd - solution - see ingredients - each 2,5 ml solution contains ipratropium bromide equivalent to ipratropium 0,5 mg salbutamol sulphate equivalent to salbutamol 2,5 mg
duolin respules combination solution
national trading and pharmaceutical est. india - 20's (2.5ml single unit dose vial x 5 x 4) - solution - combination - respiratory system-bronchodilators
garasone ophthalmic and otic solution
merck canada inc - betamethasone (betamethasone sodium phosphate); gentamicin (gentamicin sulfate) - solution - 1mg; 3mg - betamethasone (betamethasone sodium phosphate) 1mg; gentamicin (gentamicin sulfate) 3mg - antibacterials
duolin
rex medical ltd - ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020 mg; ; salbutamol sulfate 0.12mg equivalent to salbutamol 0.100 mg - aerosol inhaler, metered dose - 0.02mg/0.1mg per dose - active: ipratropium bromide monohydrate 0.021mg equivalent to ipratropium bromide anhydrous 0.020 mg salbutamol sulfate 0.12mg equivalent to salbutamol 0.100 mg excipient: heptafluoropropane lactose monohydrate - duolin hfa is indicated for the treatment of reversible bronchospasm associated with obstructive airway diseases in patients who require more than a single bronchodilator.
sultolin respirator solution nebuliser solution
square pharmaceuticals plc, pabna - salbutamol - nebuliser solution - 5 mg/ml
tobrex solution
novartis pharmaceuticals canada inc - tobramycin - solution - 0.3% - tobramycin 0.3% - antibacterials
sandoz tobramycin solution
sandoz canada incorporated - tobramycin - solution - 0.3% - tobramycin 0.3% - antibacterials